Home | Welcome to Contract Pharma   
Last Updated Sunday, July 13 2014
Print

Search Results for 'Financial Report: AMRI'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published May 6, 2014
Decline in royalties impacts results Read More »
Published April 3, 2014
AMRI has signed a definitive agreement to acquire all outstanding shares of Cedarburg Pharmaceuticals, Inc., a contract developer and manufacturer of complex API’s, for $38.2 million in cash. The transaction expands AMRI’s position as a s… Read More »
By Kristin Brooks
Published March 3, 2014
Revenues down 12% in the quarter Read More »
By Kristin Brooks
Published February 12, 2014
Achieves record contract revenues Read More »
Published November 6, 2013
Contract revenue up 16% in the quarter Read More »
Published August 6, 2013
Revenues up 19% in the quarter Read More »
Published November 6, 2012
Large-scale manufacturing revenue up 14% Read More »
Published February 9, 2009
Contract revenue for the quarter, which includes Discovery Services, Development and Small Scale Manufacturing, and Large Scale Manufacturing, was $49.6 million (+22%) and $195.5 million for the year (+20%). Read More »
Published November 7, 2008
AMRI 3Q Revenues: $61.4 million (+29%) 3Q Earnings: $7.0 million (+250%) YTD Revenues: $172.9 million (+19%) YTD Earnings: $17.4 million (+78%) Comments: Total contract revenue for the quarter was $54.1 million (+30%). Discovery Servi… Read More »
Published November 9, 2006
AMRI 3Q Revenues: $44.2 million (flat) 3Q Earnings: $1.4 million (-68%) YTD Revenues: $133.2 million (-8%) YTD Earnings: $2.9 million (-83%) Comments: Total contract revenue for the quarter was $37.9 million, up 20%. Contract reve… Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On